Ethosuximide
APC-1754
Ethosuximide
Cat. No.
APC-1754
CAS No.
77-67-8
MF
C7H11NO2
MW
141.17
Ethosuximide is a small-molecule nitrogen-containing heterocyclic compound of the succinimide class; it can be used in neuropharmacological research, the analysis of heterocyclic compounds, and quality control studies.
Technical Service Need help? Our team of experienced experts is here for you with full support.
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
CAS No.
77-67-8
MF
C7H11NO2
MW
141.17
Specification
98%
Research Area
Anticonvulsant activity;Oral LD₅₀ in mice=1.75 g/kg;i.p. LD₅₀ in mice=1.65 g/kg.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Description
Ethosuximide is a small-molecule nitrogen-containing heterocyclic compound of the succinimide class; it can be used in neuropharmacological research, the analysis of heterocyclic compounds, and quality control studies. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Inert atmosphere, 2-8°C.
References
[1]. Chen X, et al. Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression. Mol Neurodegener. 2015 Sep 29;10:51.
[2]. Sondossi K, et al. Analysis of the antiepileptic, ethosuximide impacts on neurogenesis of rat forebrain stem cells. Fundam Clin Pharmacol. 2014 Oct;28(5):512-8.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
